Form 4: Generation Bio Co. Chief Scientific Officer Matthew Stanton Ceases Section 16 Reporting Following Departure
SEC Form 4 Filing
Matthew Stanton, Chief Scientific Officer of Generation Bio Co., will no longer be subject to Section 16 reporting requirements due to his departure from the company effective January 10, 2025.
Summary
- This is a Form 4 filing indicating a change in beneficial ownership reporting status for Matthew Stanton, the Chief Scientific Officer of Generation Bio Co.
- Effective January 10, 2025, Matthew Stanton will no longer serve as the Chief Scientific Officer.
- As a result of his departure, Stanton will no longer be subject to Section 16 reporting requirements related to his transactions in Generation Bio Co.'s equity securities.
- He will no longer be required to report such transactions on Form 4 or Form 5.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an executive's departure, indicating a neutral sentiment.
Industry Context
Executive departures and changes in reporting obligations are common occurrences in publicly traded companies, particularly in the biotechnology sector. This filing reflects a standard administrative process following such a change.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Scientific Officer | Matthew Stanton | TBD | 01/10/2025 | Departure |
Stakeholder Impact
- Shareholders may be interested in the transition plan for the Chief Scientific Officer role.
- Employees may experience changes in leadership and reporting structures.
Key Dates
| Date | Description |
|---|---|
| 01/10/2025 | Effective date of Matthew Stanton's departure as Chief Scientific Officer and cessation of Section 16 reporting. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.